Filled for bankruptcy in Oct 2023
AMRS - Amyris, Inc.
NASDAQ
->
Basic Materials
->
Specialty Chemicals
EmeryVille,
United States
Type: Equity
AMRS price evolution
AMRS
| (in millions $) | 31 Mar 2023 | 31 Jan 2023 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $11.32 | $64.51 | $18.58 | $100.91 |
| Short term investments | ||||
| Net receivables | $47.68 | $97.57 | $47.84 | $46.13 |
| Inventory | $109.02 | $111.88 | $129.33 | $99.19 |
| Total current assets | $243.66 | $306.36 | $272.48 | $310.11 |
| Long term investments | ||||
| Property, plant & equipment | $290.51 | $279.59 | $258.62 | $241.6 |
| Goodwill & intangible assets | $95.52 | $189.51 | $181.32 | $191.81 |
| Total noncurrent assets | $436.02 | $518.57 | $481.58 | $479.33 |
| Total investments | ||||
| Total assets | $679.68 | $824.93 | $754.06 | $789.44 |
| Current liabilities | ||||
| Accounts payable | $200.07 | $190.49 | $133.82 | $102.96 |
| Deferred revenue | $0.03 | $0.03 | $0.95 | $0.82 |
| Short long term debt | $189.63 | $123.07 | $89.95 | $2.61 |
| Total current liabilities | $470.79 | $387.15 | $309.26 | $187.07 |
| Long term debt | $844.85 | $772.29 | $801.45 | $799.82 |
| Total noncurrent liabilities | $856.95 | $905.5 | $849.6 | $845.95 |
| Total debt | $1034.47 | $981.55 | $891.39 | $802.43 |
| Total liabilities | $1327.75 | $1313.62 | $1158.86 | $1033.03 |
| Shareholders' equity | ||||
| Retained earnings | -$3073.52 | -$2880.18 | -$2730.38 | -$2568.99 |
| Other shareholder equity | -$56.68 | -$64.11 | -$81.58 | -$61.35 |
| Total shareholder equity | -$664.36 | -$488.69 | -$427.58 | -$272.99 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $64.51 | $483.66 | $30.46 | $0.74 |
| Short term investments | ||||
| Net receivables | $97.57 | $42.74 | $44.96 | $20.19 |
| Inventory | $111.88 | $75.07 | $42.86 | $27.77 |
| Total current assets | $306.36 | $639.21 | $146.56 | $73.61 |
| Long term investments | ||||
| Property, plant & equipment | $279.59 | $112.61 | $53.01 | $55 |
| Goodwill & intangible assets | $189.51 | $170.52 | ||
| Total noncurrent assets | $518.57 | $315.09 | $76.25 | $87.36 |
| Total investments | ||||
| Total assets | $824.93 | $954.3 | $222.81 | $160.97 |
| Current liabilities | ||||
| Accounts payable | $190.49 | $79.67 | $41.05 | $51.23 |
| Deferred revenue | $0.03 | $2.53 | $4.47 | $1.35 |
| Short long term debt | $123.07 | $116.15 | $86.83 | $71.89 |
| Total current liabilities | $387.15 | $269.81 | $163.05 | $161.14 |
| Long term debt | $772.29 | $328.95 | $195.35 | $217.17 |
| Total noncurrent liabilities | $905.5 | $405.29 | $226.81 | $250 |
| Total debt | $981.55 | $445.1 | $282.19 | $289.06 |
| Total liabilities | $1313.62 | $675.09 | $389.86 | $411.13 |
| Shareholders' equity | ||||
| Retained earnings | -$2880.18 | -$2357.66 | -$2086.69 | -$1755.65 |
| Other shareholder equity | -$64.11 | -$52.77 | -$47.38 | -$43.8 |
| Total shareholder equity | -$488.69 | $246.44 | -$176.82 | -$255.78 |
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $56.08 | $75.8 | $71.13 | $65.21 |
| Cost of revenue | $51.08 | $87.92 | $65.82 | $55.93 |
| Gross Profit | $5 | -$12.12 | $5.31 | $9.28 |
| Operating activities | ||||
| Research & development | $26.77 | $28.97 | $28.78 | $26.11 |
| Selling, general & administrative | $95.87 | $135.42 | $124.71 | $126.59 |
| Total operating expenses | $219.03 | $165.57 | $153.49 | $152.7 |
| Operating income | -$214.03 | -$177.7 | -$148.18 | -$143.42 |
| Income from continuing operations | ||||
| EBIT | -$181.22 | -$143.26 | -$154.95 | -$105.39 |
| Income tax expense | -$0.86 | -$1.34 | $0.15 | -$0.69 |
| Interest expense | $12.98 | $7.88 | $6.29 | $5.3 |
| Net income | ||||
| Net income | -$193.34 | -$149.8 | -$161.4 | -$110.01 |
| Income (for common shares) | -$193.34 | -$149.8 | -$161.4 | -$110.01 |
| (in millions $) | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $269.85 | $173.14 | $152.56 | |
| Cost of revenue | $258.67 | $87.81 | $76.19 | |
| Gross Profit | $11.18 | $85.33 | $76.37 | |
| Operating activities | ||||
| Research & development | $110.22 | $71.68 | $71.46 | |
| Selling, general & administrative | $493.63 | $137.07 | $126.59 | |
| Total operating expenses | $605.04 | $208.75 | $198.26 | |
| Operating income | -$593.86 | -$123.42 | -$121.89 | |
| Income from continuing operations | ||||
| EBIT | -$506.47 | -$282.8 | -$183.47 | |
| Income tax expense | -$2.7 | $0.29 | $0.63 | |
| Interest expense | $24.73 | $47.95 | $58.66 | |
| Net income | ||||
| Net income | -$528.51 | -$331.04 | -$242.77 | |
| Income (for common shares) | -$528.51 | -$382.31 | -$270.35 | |
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Net income | -$193.34 | -$149.8 | -$161.4 | -$110.01 |
| Operating activities | ||||
| Depreciation | $12.71 | $11.8 | $5.76 | $5.67 |
| Business acquisitions & disposals | -$4.22 | |||
| Stock-based compensation | $5.79 | $12.22 | $12.26 | $12.65 |
| Total cash flows from operations | -$90 | -$92.88 | -$133.53 | -$147.04 |
| Investing activities | ||||
| Capital expenditures | -$4.82 | -$4.4 | -$30.09 | -$37.71 |
| Investments | ||||
| Total cash flows from investing | -$4.82 | -$4.4 | -$30.09 | -$41.94 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $48.58 | $3.27 | ||
| Net borrowings | $36.97 | $94.33 | $80.79 | -$0 |
| Total cash flows from financing | $41.61 | $142.91 | $81.29 | $3.26 |
| Effect of exchange rate | $0.06 | $0.33 | $0.43 | -$0.45 |
| Change in cash and equivalents | -$53.15 | $45.96 | -$81.9 | -$186.17 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$528.51 | -$270.97 | -$331.04 | -$242.77 |
| Operating activities | ||||
| Depreciation | $27.27 | $12.69 | $12.13 | $17.18 |
| Business acquisitions & disposals | -$17.76 | -$18.46 | ||
| Stock-based compensation | $48.71 | $33.39 | $13.74 | $12.55 |
| Total cash flows from operations | -$525.89 | -$181.33 | -$175.75 | -$156.93 |
| Investing activities | ||||
| Capital expenditures | -$105.95 | -$45.64 | -$12.78 | -$13.08 |
| Investments | ||||
| Total cash flows from investing | -$123.71 | -$64.1 | -$12.78 | -$13.08 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $55.94 | $175.16 | $234.4 | $54.83 |
| Net borrowings | $174.99 | $506.4 | -$39.82 | $71.51 |
| Total cash flows from financing | $231.41 | $701.96 | $222.53 | $124.91 |
| Effect of exchange rate | $0.47 | $0.36 | -$4.27 | -$0.25 |
| Change in cash and equivalents | -$417.71 | $456.89 | $29.72 | -$45.35 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 368.52M |
| Revenue | $268.22M |
|---|---|
| EBITDA | -$548.90M |
| EBIT | -$584.83M |
| Net Income | -$614.55M |
| Revenue Q/Q | -2.82% |
| Revenue Y/Y | N/A |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | -1.65 |
| Cash/Share | 0.03 |
| EPS | -$1.67 |
|---|---|
| ROA | -80.65% |
| ROE | 132.61% |
| Debt/Equity | -2.69 |
|---|---|
| Net debt/EBITDA | -2.40 |
| Current ratio | 0.52 |
| Quick ratio | 0.29 |